Anupam Rasayan India Ltd

Anupam Rasayan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Anupam Rasayan India Ltd

₹ 769 -0.20%
11 Dec 3:51 p.m.
anupamrasayan.com BSE: 543275 NSE: ANURAS
About

Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries.[1]

Key Points

Business Verticals FY24
1) Life Science Specialty Chemicals (91%):
a. Agrochemicals (65%)- Manufactures agro intermediates and agro active ingredients (insecticides, fungicides, and herbicides) for the agrochemical industry.
b. Personal Care (17%) - Manufactures antibacterial and ultraviolet protection intermediates and ingredients for the personal care industry.
c. Pharmaceuticals (9%)- The segment focuses on developing intermediates and ‘key starting materials’ for active pharmaceutical ingredients.

Website BSE NSE
  • Market Cap ₹ 8,448 Cr.
  • Current Price ₹ 769
  • High / Low ₹ 1,107 / 673
  • Stock P/E 121
  • Book Value ₹ 253
  • Dividend Yield 0.16 %
  • ROCE 8.89 %
  • ROE 4.91 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 20.6% CAGR over last 5 years

Cons

  • Stock is trading at 3.03 times its book value
  • Company has a low return on equity of 7.33% over last 3 years.
  • Debtor days have increased from 111 to 143 days.
  • Promoter holding has decreased over last 3 years: -4.17%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE 250 SmallCap Index BSE 400 MidSmallCap Index Nifty Total Market BSE Allcap BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
249 266 325 344 393 392 480 386 392 296 401 254 294
185 191 220 245 282 281 363 285 285 216 308 201 214
Operating Profit 64 75 105 99 111 111 117 101 107 79 93 53 80
OPM % 26% 28% 32% 29% 28% 28% 24% 26% 27% 27% 23% 21% 27%
6 5 -7 -8 -10 -3 24 12 3 2 12 6 2
Interest 5 5 14 12 16 14 20 18 20 25 26 22 27
Depreciation 15 16 15 16 18 18 19 19 20 20 21 21 22
Profit before tax 50 59 68 62 67 75 103 77 71 36 58 16 34
Tax % 28% 36% 33% 32% 29% 28% 29% 32% 31% 28% 30% 25% 10%
36 38 46 42 48 54 73 52 49 26 40 12 31
EPS in Rs 3.61 3.79 4.60 3.96 4.15 4.00 5.28 3.59 3.78 1.68 2.82 0.36 1.52
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
502 529 811 1,074 1,602 1,475 1,245
408 394 617 769 1,171 1,094 939
Operating Profit 93 135 194 305 431 381 305
OPM % 19% 25% 24% 28% 27% 26% 25%
19 11 26 8 10 30 22
Interest 24 45 69 31 63 89 100
Depreciation 23 29 52 60 71 80 84
Profit before tax 66 72 100 222 308 242 144
Tax % 24% 26% 30% 31% 30% 31%
49 53 70 152 217 167 109
EPS in Rs 9.85 10.64 7.04 15.18 16.84 11.72 6.38
Dividend Payout % 0% 0% 7% 7% 15% 11%
Compounded Sales Growth
10 Years: %
5 Years: 24%
3 Years: 22%
TTM: -25%
Compounded Profit Growth
10 Years: %
5 Years: 21%
3 Years: 21%
TTM: -61%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -2%
1 Year: -27%
Return on Equity
10 Years: %
5 Years: 7%
3 Years: 7%
Last Year: 5%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 50 50 100 100 107 110 110
Reserves 432 515 1,473 1,627 2,265 2,651 2,673
694 847 423 836 822 1,070 1,327
146 252 301 327 584 771 808
Total Liabilities 1,323 1,664 2,298 2,891 3,778 4,602 4,918
681 977 1,115 1,202 1,417 1,501 2,020
CWIP 191 101 43 44 120 609 267
Investments 0 0 0 149 67 67 19
451 586 1,140 1,496 2,173 2,424 2,613
Total Assets 1,323 1,664 2,298 2,891 3,778 4,602 4,918

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
39 95 1 -171 292 59
-250 -178 -193 -412 -523 -392
206 102 416 384 371 395
Net Cash Flow -6 19 224 -199 140 62

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 88 89 92 95 95 143
Inventory Days 277 515 530 852 483 627
Days Payable 105 226 215 225 167 247
Cash Conversion Cycle 260 379 408 722 410 524
Working Capital Days 168 185 233 328 253 344
ROCE % 9% 10% 11% 13% 9%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
65.40% 65.18% 65.17% 65.16% 60.96% 60.80% 60.77% 60.73% 61.41% 61.26% 61.23% 61.23%
5.73% 5.73% 4.98% 4.59% 8.19% 8.52% 9.79% 10.26% 9.13% 8.07% 7.14% 7.00%
3.75% 3.68% 4.40% 4.40% 6.18% 4.98% 3.74% 1.76% 2.51% 2.56% 2.56% 2.30%
25.12% 25.41% 25.45% 25.84% 24.67% 25.68% 25.71% 27.25% 26.96% 28.10% 29.06% 29.47%
No. of Shareholders 60,62965,07165,87071,49273,32666,50761,50461,12960,08957,62362,21863,866

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls